Pharsight

Topicort patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8715624 TARO PHARMS Stable liquid desoximethasone compositions with reduced oxidized impurity
May, 2026

(2 years from now)

US8277780 TARO PHARMS Stable liquid desoximethasone compositions with reduced oxidized impurity
Sep, 2028

(4 years from now)

Topicort is owned by Taro Pharms.

Topicort contains Desoximetasone.

Topicort has a total of 2 drug patents out of which 0 drug patents have expired.

Topicort was authorised for market use on 11 April, 2013.

Topicort is available in spray;topical dosage forms.

Topicort can be used as treatment of plaque psoriasis in patients 18 years of age or older.

The generics of Topicort are possible to be released after 01 September, 2028.

Drugs and Companies using DESOXIMETASONE ingredient

Market Authorisation Date: 11 April, 2013

Treatment: Treatment of plaque psoriasis in patients 18 years of age or older

Dosage: SPRAY;TOPICAL

How can I launch a generic of TOPICORT before it's drug patent expiration?
More Information on Dosage

TOPICORT family patents

Family Patents